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prealbumin 1.000 0.484b 0.443b 0.419b 0.016 0.012
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lean body
mass
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body cell
mass




baseline in study and control group was 125.14 and 100.97 pg/mL
respectively. At the end of 5 years, serum creatinine was 2.84 and 3.48 mg/
dL, GFR was 8.08 and 7.38 13 mL/min/1.73 m2 , serum PTH was 519.96
and 707.23 pg/mL in study and control groups respectively. Serum
phosphorous levels in study group and control group at baseline were 4.06
and 3.94 mg/dL respectively. At the end of 5 years these levels were 3.84
and 4.0 /dL respectively. The detail statistical analysis and other
observations will be presented. It has been observed that LPDþKA is
superior to LPD in delaying the progression of CKD towards the ESRD. It is
also superior to LPD in decreasing the serum phosphorus levels and thus
delaying the occurrence of secondary parahyperthyroidism and renal
osteodystrophy. In maintaining the nutritional status of the patients,
Glycemic control and blood pressure control, LPDþKA has played a role
superior to that of LPD.
http://dx.doi.org/10.1016/j.krcp.2012.04.634311
A RANDOMIZED CONTROLLED TRIAL OF DIETARY AND LIFESTYLE
MODIFICATION BASED ON THE EMPOWERMENT APPROACH AMONG
CHRONIC KIDNEY DISEASE PATIENTS
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Phramongkutklao Hospital, Bangkok, Thailand
Changes of diet and lifestyle can slow the progression of chronic kidney
disease (CKD). We aimed to study the effect of dietary modiﬁcation with or
without exercise by the empowerment approach in CKD patients. The 12-
week protocol was conducted in patients with CKD stage 3-5. The
participants were randomly assigned to be a standard care (C) group, a
diet-managed (D) group or a diet plus exercise-managed (DE) group. All
groups were advised on low protein (0.6-0.8 g/kg/day) and low salt (5 g/
day) diet. Group D and DE participated in the empowerment activities
during the study. Blood and urine were collected for nutrition evaluation.
Eighty-one patients completed the study program (96%). At baseline, there
was not signiﬁcantly difference in characteristics among the three groups,
whereas, at the end of the study, there were signiﬁcantly decreased in
systolic (SBP) and diastolic BP (DBP), and normalize protein nitrogen
appearance (nPNA) in group D and DE, when compared with C. (Table)
We summarized that dietary and lifestyle modiﬁcation based on the
empowerment approach improved SBP, DBP and reduced dietary protein
intake, and it might help CKD patients reduce salt intake.
http://dx.doi.org/10.1016/j.krcp.2012.04.635312
THE CORRELATION OF SERUM PREALBUMIN AND ROUTINE NUTRITION
PARAMETERS IN CONTINUOUS AMBULATORY PERITONEAL
DIALYSIS PATIENTS
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Prealbumin is evidenced to reﬂect recent dietary intake rather than
overall nutrition status because of its short half-life. Most of continuous
ambulatory peritoneal dialysis (CAPD) patients show hypoalbuminnemia.
However, there are many factors which may inﬂuence the level of albuminin serum. We demonstrated the correlation of prealbumin and other
common nutritional markers in CAPD patients. All participants were
undergoing peritoneal dialysis more than 3 months with no active
infection elsewhere. The participants were asked to do the handgrip
strength (HGS) by Grip strength dynamometer (T.K.K.5001) and
bioelectrical impedance analysis. Serum prealbumin, albumin and
C-reactive protein (CRP) were tested. Of 48 patients, 56% had serum
albumin less than 3.5 g/dL (3.3970.43) while prealbumin more than
0.35 g/L (0.3570.08). Sixty-eight percent of all participants had HGS
below normal value according to gender. The correlation of prealbumin
and the other nutrition parameters was shown in the table.
We concluded that HGS may be a comfortably and non invasivealternative technique used to indicate nutrition status in CAPD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.636
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Plasma adiponectin (ADPN) is markedly elevated in end-stage renal disease
(ESRD) patients compared to healthy controls. In this study, we aimed to
evaluate clinical correlates of plasma ADPN and its importance in predicting
clinical outcomes in chronic peritoneal dialysis (PD) patients. Furthermore, we
evaluated the relationship between ADPN and C-reactive protein (CRP) in
predicting outcomes of these patients. We prospectively measured plasma
ADPN, CRP and other biochemical parameters and body composition in 238
ESRD patients on maintenance PD Z3 months. Patients were followed for a
median of 48 months. The plasma ADPN was 24.6 (13.9, 39.8) and 23.0 (13.9,
32.7)mg/ml for men and women, respectively (P¼0.42). Multiple linear
regression analysis showed that log-transformed ADPN was correlated with
body fat mass (P¼0.008), residual glomerular ﬁltration rate (P¼0.005), log-
CRP (Po0.001), serum albumin (P¼0.004), triglyceride (Po0.001) and HDL-
cholesterol (Po0.001). Univariate Cox regression analysis showed that
plasma ADPN showed no signiﬁcant association with all-cause mortality and
cardiovascular death. However, stratifying patients into 4 groups on the basis
of high or low CRP and high or low ADPN (stratiﬁed by their median levels),
those with high CRP and high ADPN were dialyzed for the longest duration,
had the lowest serum albumin, lowest LDL-cholesterol and residual GFR but
highest CRP among the four groups. Body mass index and body fat mass were
the highest among patients with high CRP, low ADPN. In the multivariable
Cox regression analysis controlling for confounding covariates, patients with
high CRP and high ADPN showed a 2.33-fold (95% CI, 1.24–4.35; P¼0.008)
and 2.47-fold (95% CI, 1.09–5.63; P¼0.031) increased risk of mortality and
cardiovascular death, respectively compared to those with low CRP and high
ADPN while those with high CRP and low ADPN were not associated with a
signiﬁcantly increased risk of mortality and cardiovascular death.
In conclusion, our data suggests that high rather than low plasma ADPN is
predictive of higher mortality and more adverse cardiovascular outcomes in
association with inﬂammation in PD patients.nCorrespondenig address:
Medicine, Queen Mary Hospital, University of Hong Kong. Hong Kong
http://dx.doi.org/10.1016/j.krcp.2012.04.637
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SELF REPORTED POOR APPETITE SHOWS INDEPENDENT ASSOCIATION
WITH CARDIAC DYSFUNCTION AND CARDIOVASCULAR DISEASE IN
CHRONIC KIDNEY DISEASE
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Kong
Anorexia is common in patients with chronic kidney disease (CKD) and
predicts poor survival. We performed this prospective study with an aim to
determine factors associated with poor appetite in patients with stage 3-5
CKD. A cohort of 296 stage 3-5 CKD patients (168 men and 128 women)
was invited to grade their own appetite in the recent one month on a scale
from 1 to 4 (namely, very good, good, fair, and poor appetite, respectively).
In addition, these patients underwent echocardiographic examination and
other clinical and biochemical assessments. The mean age of these patients
was 60710 years with an average estimated glomerular ﬁltration rate
